Page 2 - Oxford University Platform Randomised Trial Of Interventions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oxford university platform randomised trial of interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oxford University Platform Randomised Trial Of Interventions Today - Breaking & Trending Today

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19


Date Time
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK’s PRINCIPLE trial in 1,779 participants.
Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial. ....

United Kingdom , Fiona Watt , Richard Hobbs , Chris Butler , Mona Bafadhel , Trial Steering Committee , United Kingdom Research , University Of Oxford , Oxford University Platform Randomised Trial Of Interventions , National Institute For Health Research , Therapeutics Task , Department Of Health , Oxford University Nuffield Department Of Medicine , Research Council , Oxford University , Platform Randomised Trial , Older People , United Kingdom Government , Chief Investigator , Professor Chris Butler , South Wales , Primary Care , Nuffield Department , Primary Care Health Sciences , United Kingdom Wide , Therapeutics Taskforce ,

Asthma drug 'reduces Covid-19 recovery time in those not admitted to hospital' | East London and West Essex Guardian Series


An inhaled, widely available, asthma drug shortens recovery time in people with coronavirus who have not been admitted to hospital, a new study suggests.
British patients will be able to access the first ever at-home Covid-19 treatment after the NHS approved budesonide for use on a “case-by-case” basis among older adults in the community, which means that GPs will be able to prescribe it to their patients.
Researchers say the discovery is a “significant milestone” for the pandemic, and that the drug, budesonide, is effective as a treatment at home and during the early stages of the illness.
Early treatment with the medication shortens recovery time by a median average of three days in those with Covid-19 who are at higher risk of more severe illness and are treated in the community, according to the research. ....

United Kingdom , Richard Hobbs , Stephen Powis , Chris Butler , Gail Hayward , Oxford University Platform Randomised Trial Of Interventions , Nuffield Department Of Primary Care Health Sciences , England National , Oxford University , Platform Randomised Trial , Older People , Professor Richard Hobbs , Nuffield Department , Primary Care Health Sciences , South Wales , Professor Gail Hayward , National Medical Director , ஒன்றுபட்டது கிஂக்டம் , ரிச்சர்ட் ஹாப்ஸ் , கிறிஸ் பட்லர் , கெயில் வைக்கோல் , நுஃபையீல்ட் துறை ஆஃப் ப்ரைமரீ பராமரிப்பு ஆரோக்கியம் அறிவியல் , இங்கிலாந்து தேசிய , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , பழையது மக்கள் , ப்ரொஃபெஸர் ரிச்சர்ட் ஹாப்ஸ் ,